Detection of Helicobacter Pylori in Ulcerative Colitis Patients

Inflammatory Bowel Diseases Clinical Trial

Official title:

Detection of Helicobacter Pylori in Colonic Tissue in Newly Diagnosed Ulcerative Colitis Patients

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03172000
• Other study ID #: IBD Helicobacter
• Status: Recruiting
• Phase: N/A
• First received: May 27, 2017
• Last updated: May 30, 2017
• Start date: March 1, 2017
• Est. completion date: December 2019

Study information

• Verified date: May 2017
• Source: Tanta University
• Contact: Sherief Abd-Elsalam, MD
• Phone: 00201147773440
• Email: Sheriefabdelsalam[@]yahoo.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Helicobacter pylori (H. pylori) infection is one of the most common infectious diseases in humans.

Description:

Several bacterial and viral agents may have a role in the aetiology of IBD. In theory, H. pylori infection could be involved in IBD by inducing alterations in gastric and/or intestinal permeability or by causing immunological derangements resulting in absorption of antigenic material and autoimmunity via various immunological pathways.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 60
• Est. completion date: December 2019
• Est. primary completion date: August 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• newly diagnosed ulcerative colitis

Exclusion Criteria:

• Other diagnosis

Related Conditions & MeSH terms

• Colitis
• Colitis, Ulcerative
• Inflammatory Bowel Diseases

Intervention

Diagnostic Test:
• Colonoscopy and biopsy
Colonoscopic biopsy were taken from the rectum, the sigmoid, descending, transverse, ascending colon, and the cecum of each patient.

Locations

Country	Name	City	State
Egypt	Tanta university - faculty of medicine	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Tanta University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of patients with Helicobacter	Number of patients with Helicobacter	6 months